MBB Public Markets I LLC grew its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 9.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,990 shares of the biopharmaceutical company’s stock after buying an additional 500 […]